Adaptive change inferred from genomic population analysis of the ST93 epidemic clone of community-associated methicillin-resistant Staphylococcus aureus

Genome Biology and Evolution

Volumn 6, Issue 2, 2014, Pages 366-378

  Stinear, Timothy P ^a,b   Holt, Kathryn E ^c   Chua, Kyra ^a,b,d   Stepnell, Justin ^a   Tuck, Kellie L ^b   Coombs, Geoffrey ^e,f   Harrison, Paul Francis ^b   Seemann, Torsten ^b   Howden, Benjamin P ^a,b,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d AUSTIN HEALTH   (Australia)

^e CURTIN UNIVERSITY   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Alpha hemolysin; Community acquired MRSA; Comparative genomics; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL TOXIN;

AUSTRALIA; BACTERIAL GENOME; BIOSYNTHESIS; CLASSIFICATION; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; EPIDEMIOLOGY; GENETICS; GENOMICS; HUMAN; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MOLECULAR GENETICS; PHYLOGENY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; AUSTRALIA; BACTERIAL TOXINS; COMMUNITY-ACQUIRED INFECTIONS; GENOME, BACTERIAL; GENOMICS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR SEQUENCE DATA; PHYLOGENY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84902981074     PISSN: None     EISSN: 17596653     Source Type: Journal    
DOI: 10.1093/gbe/evu022     Document Type: Article

References (60)

1. AGAR. 2012. Staphylococcus aureus program 2012 (SAP 2012) community survey, MRSA epidemiology and typing report. [cited 2014 Feb 10]. Available from: http://www.agargroup.org/surveys/.
2. Chua K, Laurent F, Coombs G, Grayson ML, Howden BP. 2011. Antimicrobial resistance: not community-associated methicillinresistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy. Clin Infect Dis. 52: 99-114.
3. Chua KY, et al. 2011. The dominant Australian community-acquired methicillin-resistant Staphylococcus aureus clone ST93-IV [2B] is highly virulent and genetically distinct. PLoS One 6:e25887.
4. Coombs GW, et al. 2006. Methicillin-resistant Staphylococcus aureus clones, Western Australia. Emerg Infect Dis. 12: 241-247.
5. Coombs GW, et al. 2009. Prevalence of MRSA strains among Staphylococcus aureus isolated from outpatients, 2006. Commun Dis Intell. 33: 10-20.
6. Coombs GW, et al. 2012. The molecular epidemiology of the highly virulent ST93 Australian community Staphylococcus aureus strain. PLoS One 7:e43037.
7. David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 23: 616-687.
8. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. 2010. Communityassociated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568.
9. DeLeo FR, et al. 2011. Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A. 108: 18091-18096.
10. Diep BA, Otto M. 2008. The role of virulence determinants in communityassociated MRSA pathogenesis. Trends Microbiol. 16: 361-369.
11. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 7: 214.
12. Felsenstein J. 2008. Comparative methods with sampling error and within-species variation: contrasts revisited and revised. Am Nat. 171: 713-725.
13. Fitzgerald Jr. 2013. Evolution of Staphylococcus aureus during human colonization and infection. Infect Genet Evol. pii:S1567-1348(13)00160-3.
14. Fuentes DE, et al. 2005. The product of the qacC gene of Staphylococcus epidermidis CH mediates resistance to beta-lactam antibiotics in gram-positive and gram-negative bacteria. Res Microbiol. 156: 472-477.
15. Gao W, et al. 2013. The RpoB H481Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus. J Infect Dis. 207: 929-939.
16. Gosbell IB, Mercer JL, Neville SA, Chant KG, Munro R. 2001. Communityacquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in South Western Sydney. Pathology 33: 206-210.
17. Gouy M, Guindon S, Gascuel O. 2010. SeaView version 4: a multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol Biol Evol. 27: 221-224.
18. Harris SR, et al. 2010. Evolution ofMRSA during hospital transmission and intercontinental spread. Science 327: 469-474.
19. Holden MT, et al. 2013. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res. 23: 653-664.
20. Howden BP, et al. 2013. Genomic insights to control the emergence of vancomycin-resistant enterococci. MBio 4:e00412-13.
21. Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol. 23: 254-267.
22. Kennedy AD, et al. 2008. Epidemic community-associated methicillinresistant Staphylococcus aureus: recent clonal expansion and diversification. Proc Natl Acad Sci U S A. 105: 1327-1332.
23. Khan SA, Novick RP. 1983. Complete nucleotide sequence of pT181, a tetracycline-resistance plasmid from Staphylococcus aureus. Plasmid 10: 251-259.
24. Klevens RM, et al. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J Am Med Assoc. 298: 1763-1771.
25. Komatsuzawa H, et al. 2001. Cloning and sequencing of the gene, fmtC, which affects oxacillin resistance in methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett. 203: 49-54.
26. Kurt K, et al. 2013. Subpopulations of Staphylococcus aureus clonal complex 121 are associated with distinct clinical entities. PLoS One 8: e58155.
27. Kurtz S, et al. 2004. Versatile and open software for comparing large genomes. Genome Biol. 5:R12.
28. Kwan T, Liu J, DuBow M, Gros P, Pelletier J. 2005. The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci U S A. 102: 5174-5179.
29. Lampson BC, Parisi JT. 1986. Naturally occurring Staphylococcus epidermidis plasmid expressing constitutive macrolide-lincosamide-streptogramin B resistance contains a deleted attenuator. J Bacteriol. 166: 479-483.
30. Li M, et al. 2009. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 106: 5883-5888.
31. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. 1996. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust. 164: 721-723.
32. McAdam PR, et al. 2012. Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A. 109: 9107-9112.
33. Moran GJ, et al. 2006. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 355: 666-674.
34. Munckhof WJ, Schooneveldt J, Coombs GW, Hoare J, Nimmo GR. 2003. Emergenceofcommunity-acquiredmethicillin-resistantStaphylococcus aureus (MRSA) infection in Queensland, Australia. Int J Infect Dis. 7: 259-264.
35. Nimmo GR, Coombs GW. 2008. Community-associated methicillinresistant Staphylococcus aureus (MRSA) in Australia. Int J Antimicrob Agents. 31: 401-410.
36. Nimmo GR, Schooneveldt J, O'Kane G, McCall B, Vickery A. 2000. Community acquisition of gentamicin-sensitive methicillin-resistant Staphylococcus aureus in southeast Queensland, Australia. J Clin Microbiol. 38: 3926-3931.
37. Nimmo GR, et al. 2006. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust. 184: 384-388.
38. Nourse C, Starr M, Munckhof W. 2007. Community-acquired methicillinresistant Staphylococcus aureus causes severe disseminated infection and deep venous thrombosis in children: literature review and recommendations for management. J Paediatr Child Health. 43: 656-661.
39. Nubel U, et al. 2010. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog. 6:e1000855.
40. Paulander W, et al. 2013. Antibiotic-mediated selection of quorumsensing- negative Staphylococcus aureus. MBio 3:e00459-e00512.
41. Peleg AY, Munckhof WJ. 2004. Fatal necrotising pneumonia due to community- acquired methicillin-resistant Staphylococcus aureus (MRSA). Med J Aust. 181: 228-229.
42. Peleg AY, Munckhof WJ, Kleinschmidt SL, Stephens AJ, Huygens F. 2005. Life-threatening community-acquired methicillin-resistant Staphylococcus aureus infection in Australia. Eur J Clin Microbiol Infect Dis. 24: 384-387.
43. Risson DC, O'Connor ED, Guard RW, Schooneveldt JM, Nimmo GR. 2007. A fatal case of necrotising pneumonia due to community-associated methicillin-resistant Staphylococcus aureus.Med J Aust. 186: 479-480.
44. Rouch DA, Messerotti LJ, Loo LS, Jackson CA, Skurray RA. 1989. Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257. Mol Microbiol. 3: 161-175.
45. Rudkin JK, et al. 2012. Methicillin resistance reduces the virulence of healthcare-associated methicillin-resistant Staphylococcus aureus by interfering with the agr quorum sensing system. J Infect Dis. 205: 798-806.
46. Rudkin JK, et al. 2014. Oxacillin alters the toxin expression profile of community associated-MRSA. Antimicrob Agents Chemother. 58: 1100-1107.
47. Rumble SM, et al. 2009. SHRiMP: accurate mapping of short color-space reads. PLoS Comput Biol. 5:e1000386.
48. Seybold U, et al. 2006. Emergence of community-associated methicillinresistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis. 42: 647-656.
49. Shepheard MA, et al. 2013. Historical zoonoses and other changes in host tropism of Staphylococcus aureus, identified by phylogenetic analysis of a population dataset. PLoS One 8:e62369.
50. Shopsin B, et al. 2008. Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J Infect Dis. 198: 1171-1174.
51. Spoor LE, et al. 2013. Livestock origin for a human pandemic clone of community- associated methicillin-resistant Staphylococcus aureus. MBio 4: e00356-13.
52. Stamatakis A, Ludwig T, Meier H. 2005. RAxML-III: a fast program for maximum likelihood-based inference of large phylogenetic trees. Bioinformatics 21: 456-463.
53. Tong SY, et al. 2008. Fatal community-associated methicillinresistant Staphylococcus aureus pneumonia after influenza. Med J Aust. 188: 61.
54. Tong SY, et al. 2009. High-resolution melting analysis of the spa locus reveals significant diversity within sequence type 93 methicillinresistant Staphylococcus aureus from northern Australia. Clin Microbiol Infect. 15: 1126-1131.
55. Tong SY, et al. 2013. Virulence of endemic nonpigmented northern Australian Staphylococcus aureus clone (clonal complex 75, S. argenteus) is not augmented by staphyloxanthin. J Infect Dis. 208: 520-527.
56. Udo EE, Pearman JW, Grubb WB. 1993. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect. 25: 97-108.
57. Uhlemann AC, Otto M, Lowy FD, Deleo FR. 2013. Evolution of community- and healthcare-associated methicillin-resistant Staphylococcus aureus. Infect Genet Evol. 563-574.
58. Vandenesch F, et al. 2003. Community-acquired methicillinresistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 9: 978-984.
59. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18: 821-829.
60. Zinn CS, Westh H, Rosdahl VT. 2004. An internationalmulticenter study of antimicrobial resistance and typing of hospital Staphylococcus aureus isolates from 21 laboratories in 19 countries or states. Microb Drug Resist. 10: 160-168.